Next Generation Gene Therapeutics

China
Fucheng, Shanxi, China

Company profile

Next Generation Gene Therapeutics company profile

Next Generation Gene Therapeutics is a healthcare company that engages in the research and development of gene therapy. Its unique propriety technology of "one target and two bullets" can provide effective treatment for a variety of genetic diseases that currently have few therapeutic methods in the world. NGGT was founded in March 2020 by senior scientists and entrepreneurs in the field of gene therapy. It is committed to becoming the world's leading gene therapy company with international influence. The company has successful experience in the whole industry chain, concerning the early development of gene therapy products, the large-scale production of viral vectors, the construction of quality standards, international multi-center clinical research, and the application for the marketing of gene therapy products.

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2020-03-01, Month

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$70M
Last funding
Series B / $40M / 2023-07-11
Last equity funding
Series B / $40M
Investors
8
Lead investors
2
Articles
4

Founders and investors

Lead investors

Kington CapitalShanghai Biomedical Industrial Equity Investment Fund

Investors

BioVentureDT Capital PartnersLeadervc.comNorthern Light Venture CapitalShanghai Biomedical Industrial Equity Investment Fund